These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10203002)

  • 1. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.
    Günal AI; Celiker H; Dönder E; Günal SY
    J Nephrol; 1999; 12(1):38-40. PubMed ID: 10203002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
    Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
    Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography.
    Rocchi L; Feola I; Calvani M; D'Iddio S; Alfarone C; Frascarelli M
    Drugs Exp Clin Res; 1986; 12(8):707-11. PubMed ID: 3757765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
    Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
    Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
    Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
    Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
    Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine in metabolic disease: potential for pharmacological intervention.
    Arduini A; Bonomini M; Savica V; Amato A; Zammit V
    Pharmacol Ther; 2008 Nov; 120(2):149-56. PubMed ID: 18793670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
    Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
    Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients.
    González-Ortiz M; Hernández-González SO; Hernández-Salazar E; Martínez-Abundis E
    Ann Nutr Metab; 2008; 52(4):335-8. PubMed ID: 18714152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-carnitine supplementation on secondary hyperparathyroidism and bone metabolism in hemodialyzed patients.
    Cibulka R; Racek J; Pikner R; Rajdl D; Trefil L; Vesela E; Studenovska M; Siroka R
    Calcif Tissue Int; 2007 Aug; 81(2):99-106. PubMed ID: 17622482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V; Nuzziello M; Pallotta G; Sacchetti A; Petrarulo F
    J Nephrol; 2000; 13(6):444-9. PubMed ID: 11132761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
    Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
    Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
    Reuter SE; Faull RJ; Ranieri E; Evans AM
    Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.
    Perna AF; Acanfora F; Satta E; Lombardi C; Capasso R; Ingrosso D; De Santo NG
    J Nephrol; 2007; 20(1):63-5. PubMed ID: 17347975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine in dialysed patients: the choice of dosage regimen.
    Berard E; Iordache A; Barrillon D; Bayle J
    Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.